AXIN1 is involved in the Wnt/β-catenin signaling pathway, and loss-of-function mutations in AXIN1 in liver cancer are associated with an enrichment of signals related to the cell cycle as well as a more aggressive phenotype [28]. This evidence concerns the gene AXIN1 and liver cancer.